Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Free Research Reports on BGMD, BIOF, GEVO and MLNX Issued by the Bedford Report

BGMD, GRBK, GEVO
Free Research Reports on BGMD, BIOF, GEVO and MLNX Issued by the Bedford Report
http://media.marketwire.com/attachments/201211/53317_equitynewscircuit-logo-final.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1004511&ProfileId=051205&sourceType=1

NEW YORK, NY -- (Marketwired) -- 04/08/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

BG Medicine, Inc. (NASDAQ: BGMD) shares have declined approximately 25 percent year-to-date. The company in their recent earnings release stated that they expect to launch the CardioSCORE test in Europe sometime in the first half of 2013.

Find out more about BG Medicine including full access to the free equity report at: www.BedfordReport.com/BGMD

BioFuel Energy Corp. (NASDAQ: BIOF) shares have surged over 30 percent year-to-date. The company has recently engaged Piper Jaffray & Co. as a financial advisor to assist them in exploring strategic alternatives that may include the sale of one or both of BioFuel's plants.

Find out more about BioFuel Energy including full access to the free equity report at: www.BedfordReport.com/BIOF

Gevo, Inc. (NASDAQ: GEVO) shares have gained approximately 35 percent year-to-date. The company is focused on developing biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. Gevo reported a net loss of $13.2 million for the fourth quarter of 2012, compared to a net loss of 14.2 million in the year ago quarter.

Find out more about Gevo including full access to the free equity report at: www.BedfordReport.com/GEVO

Mellanox Technologies, Ltd. (NASDAQ: MLNX) shares have gained approximate 8 percent in the past month. The company has announced it will release results for the first quarter of 2013 after market close on Wednesday, April 24th.

Find out more about Mellanox Technologies including full access to the free equity report at: www.BedfordReport.com/MLNX

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today